Marker Therapeutics Stock Pattern Recognition Thrusting Pattern

MRKR Stock

USD 1.33 -0.02 -1.48%

This pattern recognition tool runs Thrusting Pattern recognition and companion studies for Marker Therapeutics. This view tracks pattern recognition signals tied to momentum and continuation to support structured performance interpretation without implying advice.

Symbol

Recognition

The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was eleven with a total number of output elements of fifty. The function did not return any valid pattern recognition events for the selected time horizon. The Thrusting Pattern describes Marker Therapeutics bearish continuation trend.

Marker Therapeutics Technical Analysis Modules

Most technical analysis of Marker Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Marker from various momentum indicators to cycle indicators. When you analyze Marker charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

Stock Overview, Methodology & Data Sources

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. The company was founded in 1999 and is headquartered in Houston, Texas. Marker Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 56 people. Operational efficiency and capital allocation discipline are central to the long-run profile of Marker Therapeutics. The company is currently operating at a loss. Marker Therapeutics has a market cap of 17.21 M, ROE of -110.67%.

Methodology

Unless otherwise specified, financial data for Marker Therapeutics is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Marker (USA Stocks:MRKR) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: The dataset for Marker Therapeutics incorporates public filings and market reference sources and official institutional disclosures, including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Some inputs may not update instantaneously. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Marker Therapeutics may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

This content is curated and reviewed by:

Vlad Skutelnik - Macroaxis Contributor

Be your own money manager

Tracking Marker Therapeutics inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Generate Optimal Portfolios

Align your risk and return expectations

By capturing risk tolerance and investment horizon, Macroaxis optimization evaluates acceptable risk for target return profiles. The process summarizes how much risk can be taken for a given return goal.

Fix portfolios for free

Additional Tools for Marker Stock Analysis

	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Equity Valuation Check real value of public entities based on technical and fundamental data
	CEOs Directory Screen CEOs from public companies around the world
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC